What You Should Know:
- Topography Health, a clinical trials startup focused on community physicians, today launched out of stealth with $27.5M in funding from Andreessen Horowitz and Bain Capital Ventures.
- Co-founded by former Gerson Lehrman Group CEO Alexander Saint-Amand, Topography is making it possible for your family doctor to offer clinical drug trials as part of their practice. Not just for potentially terminal illnesses, but also for moderate chronic illnesses, where the
Read More
Sema4 Acquires GeneDx for $623M to Strengthen AI-Driven Genomic Platform
What You Should Know:
- Today, Sema4 (Nasdaq: SMFR), a health intelligence company, announced it has signed a definitive agreement to acquire GeneDx, a leader in genomic testing and analysis, at a purchase price representing approximately $623 million, strengthening its market-leading health intelligence and genomic screening offerings.
- The combined company is projected to deliver $350 million in pro forma 2022 revenue. In connection with the acquisition,
Read More
ONC Publishes the Trusted Exchange Framework and the Common Agreement
What You Should Know:
- The Office of the National Coordinator for Health IT (ONC) and its Recognized Coordinating Entity (RCE), The Sequoia Project, published the Trusted Exchange Framework and Common Agreement (TEFCA), creating the baseline legal and technical requirements that will enable secure, nationwide information sharing across different health care entities, completing a critical 21st Century Cures Act requirement.
- The release of TEFCA today marks the beginning of the
Read More
How Will AI Continue to Shape Healthcare in 2022? 9 Predictions to Watch
Digital health executives share their predictions on how artificial intelligence (AI) will continue to shape the healthcare industry in 2022.
Diana Nole, EVP and GM of Healthcare at Nuance Communications, Inc.
AI will find more game-changing use cases – According to Optum's fourth annual survey on AI in healthcare, 96% of respondents said AI plays an important role in increasing health equity, and 94% said they have a duty to ensure AI is used responsibly in healthcare. As healthcare
Read More
Jumpstart Health Launches $55M Venture Fund for Black Founded Health Startups
What You Should Know:
- Jumpstart Health Investors, announced this week the launch of Jumpstart Nova, the first venture fund to invest in Black founded and led healthcare innovation companies.
- The $55M fund will invest exclusively in Black founder-led healthcare companies across health IT, digital health, tech-enabled services, diagnostic devices, biotech, medical device manufacturing and consumer health and wellness.
Why It Matters
Marcus Whitney, a leader in healthcare innovation
Read More
Verana Health Raises $150M to Expand Real-World Data Network
What You Should Know:
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, today announced a $150 million Series E funding round led by Johnson & Johnson Innovation - JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of Novo Holdings.
- Existing Verana Health investors GV (formerly Google Ventures), Casdin Capital, and Brook Byers also joined the round, as well as notable
Read More
Improvements in Data Quality Could Yield Up to $42.1M for Healthcare Organizations
What You Should Know:
- InterSystems and Sage Growth Partners announced research that reveals just how much healthcare organizations could save from investing in higher quality data - including up to $42.1 million over the course of three years.
Report Background
According to the respondents from 100 C-level leaders from top healthcare organizations, hospitals, and healthcare systems are using inefficient practices that can impose a significant financial burden. The research found that
Read More
Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X
What You Should Know:
- New data from Tufts and Medable reveal on average, decentralized clinical trials (DCTs) are associated with reduced clinical trial timelines and can achieve net financial benefits ranging from five to 14 times for Phase II and Phase III trials, respectively.
- The findings are based on financial modeling and analysis of trial data from the Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine, and more than 150 clinical trials
Read More
Sanofi Taps BrightInsight for Development of Software as a Medical Device
What You Should Know:
- Sanofi, a global biopharmaceutical company focused on human health has inked a strategic partnership with BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solution to bring to market a next-generation digital companion application for one of Sanofi’s products.
- The BrightInsight® Platform has been selected to serve as the underlying infrastructure to accelerate continuous development of one of Sanofi’s
Read More
Chronus Health Raises $22M for Portable, Rapid Blood Analyzer Technology
What You Should Know:
- Chronus Health, a point-of-care diagnostics company raises $22M in Series A funding led by Tarsadia Investments with participation from Monta Vista Capital, SOSV, Savantus Ventures, and an undisclosed strategic investor.
- Chronus intends to use the proceeds of the Series A financing to scale its research, engineering, and data science teams, in addition to accelerating the company’s product and technology development.
Diagnostics on Demand. Reimagined
While
Read More
